Putnam Investments’s Vincerx Pharma, Inc. Unit VINCU Stock Holding History

Putnam Investments’s Portfolio VINCU Stock Details VINCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-500,000	Closed	-$11.3M	–	874
2020 Q4	$11.3M	Buy	+500,000	New	+$9.63M	0.02%	351

Other funds holding VINCU

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Putnam Investments's VINCU Position: Q1 2021 in Review

Putnam Investments sold out of Vincerx Pharma, Inc. Unit (VINCU) in Q1 2021, closing a stake of 500,000 shares — an estimated $11.3M sold.

Putnam Investments first reported a position in VINCU in Q4 2020 and held it in 1 quarter. The position peaked at $11.3M in Q4 2020. 2 funds tracked by Wall St. Rank hold VINCU as of Q1 2021.

Putnam Investments reported no remaining Vincerx Pharma, Inc. Unit position as of Q1 2021 after selling out during the quarter.
Putnam Investments sold 500,000 Vincerx Pharma, Inc. Unit shares in Q1 2021, an estimated $11.3M.
Putnam Investments first reported a position in Vincerx Pharma, Inc. Unit in Q4 2020 and held it in 1 quarter.
Putnam Investments's Vincerx Pharma, Inc. Unit position peaked at $11.3M in Q4 2020.
2 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Unit as of Q1 2021.

Based on Putnam Investments's 13F filing for Q1 2021, filed 17 May 2021.